Precision Neuroscience’s Product Chief Assumes New Role

Precision Neuroscience Corporation (Precision) has appointed Chief Product Officer Craig Mermel as chief AI and Data Officer (CAIDO) to lead the company’s artificial intelligence (AI) and data strategy, overseeing the development and deployment of its neural dataset—the most diverse collection of high-resolution neural data ever assembled.

The move reflects the growing importance of neural data to medicine and AI and the recognition that not all neural data is equal, according to the company. Unlike imaging technologies that measure brain activity indirectly, Layer 7 records directly from the cortical surface, producing high-resolution data on the way the brain functions in real time. Precision’s dataset now spans more than 75 patients and multiple brain regions, with potential applications in drug discovery, AI training, and neurological disease treatment.

“Neural data recorded directly from the brain’s cortical surface is one of the most powerful new resources in science and technology—with the potential to reshape how we treat disease, train AI, and understand human intelligence,” Precision Neurosciences CEO Michael Mager stated. “This is what Precision is uniquely positioned to pioneer, and Craig will lead that charge.”

Mermel has driven Precision’s AI adoption across its research, engineering, clinical, and operational teams. In his new role, he will lead development of the company’s data pipeline, including the labeling, segmentation, and structuring of its neural data into a scalable asset. He will also oversee the company’s approach to security and patient privacy, ensuring its systems meet the highest ethical standards.

Mermel is a pathologist and data scientist whose work focuses on applying AI to the life sciences. He joined Precision from Google, where he led teams applying AI to cancer diagnosis and treatment. Before that, he was at Apple, where he helped develop health and fitness features for the Apple Watch.

“It’s a thrilling time to be working at the intersection of data science and human health,” Mermel said. “For the first time, we are collecting data that lets us study the brain’s activity directly, rather than relying on indirect measures. The challenge now is to turn that data into something usable—to build the models, systems, and insights that can push medicine and science forward.”

Precision Neuroscience is working to provide breakthrough treatments for neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing high-bandwidth data.